CollPlant (TLV:CLPT) a biotechnology company based in Israel, has created a division to develop collagen-based BioInk for 3D printing. The BioInk is intended for use in 3D bioprinters used to make therapeutic patches and replacement organ tissues. "Recombinant human" collagen technology CollPlant has been researching the BioInk material for several years as part of its rhCollagen technology.CollPlant establish division for 3D printing with the most abundant protein in the body
CollPlant (TLV:CLPT) a biotechnology company based in Israel, has created a division to develop collagen-based BioInk for 3D printing. The BioInk is intended for use in 3D bioprinters used to make therapeutic patches and replacement organ tissues. "Recombinant human" collagen technology CollPlant has been researching the BioInk material for several years as part of its rhCollagen technology.
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon